QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
Log in
NASDAQ:KDMN

Kadmon News Headlines

$4.84
-0.02 (-0.41 %)
(As of 01/19/2021 09:01 AM ET)
Add
Compare
Today's Range
$4.84
Now: $4.84▼
$4.84
50-Day Range
$3.87
MA: $4.24▼
$4.73
52-Week Range
$2.30
Now: $4.84▼
$5.50
Volume187 shs
Average Volume3.90 million shs
Market Capitalization$830.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.68

Headlines

Kadmon (NASDAQ KDMN) News Headlines Today

Source:
SourceHeadline
Kadmon (NYSE:KDMN) Stock Rating Upgraded by Zacks Investment ResearchKadmon (NYSE:KDMN) Stock Rating Upgraded by Zacks Investment Research
marketbeat.com - November 12 at 3:09 AM
Cantor Fitzgerald Reaffirms Overweight Rating for Kadmon (NYSE:KDMN)Cantor Fitzgerald Reaffirms Overweight Rating for Kadmon (NYSE:KDMN)
marketbeat.com - October 13 at 7:19 AM
Kadmons (KDMN) Buy Rating Reiterated at OppenheimerKadmon's (KDMN) Buy Rating Reiterated at Oppenheimer
marketbeat.com - September 22 at 10:22 AM
ValuEngine Upgrades Kadmon (NYSE:KDMN) to "Buy"ValuEngine Upgrades Kadmon (NYSE:KDMN) to "Buy"
marketbeat.com - August 18 at 11:13 PM
Steven Cohen Boosts Kadmon Holdings Stake - Yahoo FinanceSteven Cohen Boosts Kadmon Holdings Stake - Yahoo Finance
finance.yahoo.com - January 15 at 11:45 PM
Kadmon gains 5% after Point72 discloses 5.3% stake - Seeking AlphaKadmon gains 5% after Point72 discloses 5.3% stake - Seeking Alpha
seekingalpha.com - January 15 at 9:48 AM
6 Stocks Moving In Thursdays After-Hours Session - Benzinga6 Stocks Moving In Thursday's After-Hours Session - Benzinga
benzinga.com - January 14 at 10:07 PM
Kadmon Holdings, Inc. (NASDAQ:KDMN) Analysts Just Slashed Next Years Revenue Estimates By 22% - Yahoo FinanceKadmon Holdings, Inc. (NASDAQ:KDMN) Analysts Just Slashed Next Year's Revenue Estimates By 22% - Yahoo Finance
finance.yahoo.com - January 14 at 5:07 PM
Kadmon Holdings, Inc. (NASDAQ:KDMN) Analysts Just Slashed Next Years Revenue Estimates By 22%Kadmon Holdings, Inc. (NASDAQ:KDMN) Analysts Just Slashed Next Year's Revenue Estimates By 22%
finance.yahoo.com - January 14 at 5:58 AM
Kadmon (NASDAQ:KDMN) Trading 10.3% Higher Kadmon (NASDAQ:KDMN) Trading 10.3% Higher
americanbankingnews.com - January 13 at 9:41 PM
Kadmon (NYSE:KDMN) Trading 5.4% Higher Kadmon (NYSE:KDMN) Trading 5.4% Higher
americanbankingnews.com - December 30 at 8:26 PM
Israeli Election, Take Four: Conservatives vs. Conservatives - The New York TimesIsraeli Election, Take Four: Conservatives vs. Conservatives - The New York Times
nytimes.com - December 23 at 6:50 PM
Kadmon Holdings, Inc. (NASDAQ:KDMN) Shares Could Be 47% Below Their Intrinsic Value EstimateKadmon Holdings, Inc. (NASDAQ:KDMN) Shares Could Be 47% Below Their Intrinsic Value Estimate
finance.yahoo.com - December 14 at 9:54 AM
Kadmon Holdings, Inc.: Kadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual MeetingKadmon Holdings, Inc.: Kadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
finanznachrichten.de - December 7 at 10:29 PM
Kadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting - Yahoo FinanceKadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting - Yahoo Finance
finance.yahoo.com - December 6 at 5:48 PM
Kadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual MeetingKadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
finance.yahoo.com - December 6 at 5:20 PM
Kadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease - Yahoo FinanceKadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease - Yahoo Finance
finance.yahoo.com - November 30 at 9:28 PM
Kadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease - StreetInsider.comKadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease - StreetInsider.com
streetinsider.com - November 30 at 4:28 PM
FDA accepts Kadmon belumosudil application for graft-versus-host disease, shares up 4%FDA accepts Kadmon belumosudil application for graft-versus-host disease, shares up 4%
seekingalpha.com - November 30 at 9:48 AM
Kadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host DiseaseKadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease
finance.yahoo.com - November 30 at 9:48 AM
Kadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting - Yahoo FinanceKadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting - Yahoo Finance
finance.yahoo.com - November 24 at 9:15 AM
Kadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual MeetingKadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting
finance.yahoo.com - November 24 at 9:15 AM
Kadmon Holdings, Inc. (NASDAQ:KDMN) Just Released Its Third-Quarter Earnings: Heres What Analysts Think - Yahoo FinanceKadmon Holdings, Inc. (NASDAQ:KDMN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
finance.yahoo.com - November 8 at 12:25 PM
Kadmon Holdings, Inc. (NASDAQ:KDMN) Just Released Its Third-Quarter Earnings: Heres What Analysts ThinkKadmon Holdings, Inc. (NASDAQ:KDMN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
finance.yahoo.com - November 8 at 12:25 PM
Kadmon EPS beats by $0.02, beats on revenueKadmon EPS beats by $0.02, beats on revenue
seekingalpha.com - November 6 at 4:39 PM
Kadmon Provides Business Update and Reports Third Quarter 2020 Financial Results - Yahoo FinanceKadmon Provides Business Update and Reports Third Quarter 2020 Financial Results - Yahoo Finance
finance.yahoo.com - November 5 at 11:42 PM
Kadmon Provides Business Update and Reports Third Quarter 2020 Financial Results - StreetInsider.comKadmon Provides Business Update and Reports Third Quarter 2020 Financial Results - StreetInsider.com
streetinsider.com - November 5 at 6:42 PM
Kadmon Provides Business Update and Reports Third Quarter 2020 Financial ResultsKadmon Provides Business Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 6:42 PM
Kadmon Holdings, Inc.: Kadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual MeetingKadmon Holdings, Inc.: Kadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
finanznachrichten.de - November 5 at 1:42 PM
Kadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting - Yahoo FinanceKadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting - Yahoo Finance
finance.yahoo.com - November 4 at 5:13 PM
Kadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual MeetingKadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
finance.yahoo.com - November 4 at 5:13 PM
Kadmon Holdings (NYSE:KDMN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Yahoo FinanceKadmon Holdings (NYSE:KDMN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Yahoo Finance
finance.yahoo.com - October 26 at 2:06 PM
Kadmon Holdings (NYSE:KDMN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, AnywayKadmon Holdings (NYSE:KDMN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
finance.yahoo.com - October 26 at 2:06 PM
Kadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancers 35th Anniversary Annual Meeting - Yahoo FinanceKadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer's 35th Anniversary Annual Meeting - Yahoo Finance
finance.yahoo.com - October 20 at 7:33 PM
Kadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer's 35th Anniversary Annual MeetingKadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer's 35th Anniversary Annual Meeting
finance.yahoo.com - October 20 at 7:33 PM
Kadmon Holdings, Inc.: Kadmon to Transfer U.S. Stock Exchange Listing to NasdaqKadmon Holdings, Inc.: Kadmon to Transfer U.S. Stock Exchange Listing to Nasdaq
finanznachrichten.de - October 15 at 8:44 AM
Kadmon to transfer listing to Nasdaq - Seeking AlphaKadmon to transfer listing to Nasdaq - Seeking Alpha
seekingalpha.com - October 14 at 3:25 AM
Kadmon to Transfer US Stock Exchange Listing to Nasdaq - StreetInsider.comKadmon to Transfer US Stock Exchange Listing to Nasdaq - StreetInsider.com
streetinsider.com - October 13 at 10:24 PM
Kadmon to Transfer U.S. Stock Exchange Listing to Nasdaq - Yahoo FinanceKadmon to Transfer U.S. Stock Exchange Listing to Nasdaq - Yahoo Finance
finance.yahoo.com - October 13 at 5:07 PM
Kadmon Announces Submission of New Drug Application to the U.S. FDA for Belumosudil in Patients with Chronic Graft-Versus-Host DiseaseKadmon Announces Submission of New Drug Application to the U.S. FDA for Belumosudil in Patients with Chronic Graft-Versus-Host Disease
finance.yahoo.com - October 11 at 10:48 PM
Kadmon files U.S. application for belumosudil in GVHD - Seeking AlphaKadmon files U.S. application for belumosudil in GVHD - Seeking Alpha
seekingalpha.com - September 30 at 11:51 PM
Kadmon files US application for belumosudil in GVHD - Seeking AlphaKadmon files US application for belumosudil in GVHD - Seeking Alpha
seekingalpha.com - September 30 at 6:49 PM
Genprex Names Seasoned IP Executive, Thomas C. Gallagher, as Senior Vice President of Intellectual Property and Licensing - StreetInsider.comGenprex Names Seasoned IP Executive, Thomas C. Gallagher, as Senior Vice President of Intellectual Property and Licensing - StreetInsider.com
streetinsider.com - September 21 at 1:14 PM
Who Has Been Buying Kadmon Holdings, Inc. (NYSE:KDMN) Shares? - Yahoo FinanceWho Has Been Buying Kadmon Holdings, Inc. (NYSE:KDMN) Shares? - Yahoo Finance
finance.yahoo.com - September 12 at 9:37 AM
Who Has Been Buying Kadmon Holdings, Inc. (NYSE:KDMN) Shares?Who Has Been Buying Kadmon Holdings, Inc. (NYSE:KDMN) Shares?
finance.yahoo.com - September 11 at 3:01 PM
FDA Grants Orphan Drug Designation to Kadmons Belumosudil for the Treatment of Systemic SclerosisFDA Grants Orphan Drug Designation to Kadmon's Belumosudil for the Treatment of Systemic Sclerosis
baystreet.ca - September 9 at 8:31 AM
FDA Grants Orphan Drug Designation to Kadmons Belumosudil for the Treatment of Systemic Sclerosis - Yahoo FinanceFDA Grants Orphan Drug Designation to Kadmon's Belumosudil for the Treatment of Systemic Sclerosis - Yahoo Finance
finance.yahoo.com - September 8 at 12:29 PM
FDA Grants Orphan Drug Designation to Kadmon's Belumosudil for the Treatment of Systemic SclerosisFDA Grants Orphan Drug Designation to Kadmon's Belumosudil for the Treatment of Systemic Sclerosis
finance.yahoo.com - September 8 at 12:29 PM
Kadmon to Present at Upcoming Investor Conferences - Yahoo FinanceKadmon to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - September 2 at 10:04 AM
Kadmon to Present at Upcoming Investor ConferencesKadmon to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 10:04 AM
Kadmon Holdings, Inc.: Kadmon Announces Appointment of Nancy Miller-Rich to Board of DirectorsKadmon Holdings, Inc.: Kadmon Announces Appointment of Nancy Miller-Rich to Board of Directors
finanznachrichten.de - August 14 at 8:14 AM
Kadmon (KDMN) Adds Nancy Miller-Rich to Board - StreetInsider.comKadmon (KDMN) Adds Nancy Miller-Rich to Board - StreetInsider.com
streetinsider.com - August 13 at 7:46 PM
Kadmon Announces Appointment of Nancy Miller-Rich to Board of Directors - Yahoo FinanceKadmon Announces Appointment of Nancy Miller-Rich to Board of Directors - Yahoo Finance
finance.yahoo.com - August 13 at 7:46 PM
Kadmon Announces Appointment of Nancy Miller-Rich to Board of DirectorsKadmon Announces Appointment of Nancy Miller-Rich to Board of Directors
finance.yahoo.com - August 13 at 7:46 PM
This page was last updated on 1/19/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.